Zobrazeno 1 - 10
of 482
pro vyhledávání: '"Britta, Wahren"'
Autor:
Britta Wahren
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 18, Iss 4 (2022)
Externí odkaz:
https://doaj.org/article/aabe1d96a1864f9584b02b53b2610054
Autor:
Stefan Petkov, Elizaveta Starodubova, Anastasia Latanova, Athina Kilpeläinen, Oleg Latyshev, Simons Svirskis, Britta Wahren, Francesca Chiodi, Ilya Gordeychuk, Maria Isaguliants
Publikováno v:
PLoS ONE, Vol 16, Iss 2, p e0247239 (2021)
[This corrects the article DOI: 10.1371/journal.pone.0197902.].
Externí odkaz:
https://doaj.org/article/044ef7a3546e4d0da854c6c7f1029b10
Autor:
Agricola Joachim, Mohamed I. M. Ahmed, Georgios Pollakis, Lisa Rogers, Verena S. Hoffmann, Patricia Munseri, Said Aboud, Eligius F. Lyamuya, Muhammad Bakari, Merlin L. Robb, Britta Wahren, Eric Sandstrom, Charlotta Nilsson, Gunnel Biberfeld, Christof Geldmacher, Kathrin Held
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
In the RV144 trial, to date the only HIV-1 vaccine efficacy trial demonstrating a modestly reduced risk of HIV-1 acquisition, antibody responses toward the HIV Envelope protein (Env) variable (V) 2 and V3 regions were shown to be correlated with a re
Externí odkaz:
https://doaj.org/article/a6153add16474f8d869ab4d4e5ed1cb1
Autor:
Jose H Arteaga, Jorma Hinkula, Edvard C.I Smith, Britta Wahren, Abdalla J. Mohamed, Maria E. Cardona, Kristin Gustafsson, Birger Christensson
Publikováno v:
Molecular Biology Reports. 49:11187-11192
Treatment with RNAi against HIV-1 transcripts efficiently inhibits viral replication but induces selection of escape mutants; therefore, the CCR5 coreceptor was suggested as an additional target. Blocking viral and host transcripts improved the antiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8fe54446ea0ada4efdf481db98f99483
https://doi.org/10.1007/s11033-022-07899-9
https://doi.org/10.1007/s11033-022-07899-9
Autor:
Maria Isaguliants, Olga Krotova, Stefan Petkov, Juris Jansons, Ekaterina Bayurova, Dzeina Mezale, Ilze Fridrihsone, Athina Kilpelainen, Philip Podschwadt, Yulia Agapkina, Olga Smirnova, Linda Kostic, Mina Saleem, Oleg Latyshev, Olesja Eliseeva, Anastasia Malkova, Tatiana Gorodnicheva, Britta Wahren, Ilya Gordeychuk, Elizaveta Starodubova, Anastasia Latanova
Publikováno v:
Microorganisms, Vol 9, Iss 6, p 1219 (2021)
Therapeutic DNA-vaccination against drug-resistant HIV-1 may hinder emergence and spread of drug-resistant HIV-1, allowing for longer successful antiretroviral treatment (ART) up-to relief of ART. We designed DNA-vaccines against drug-resistant HIV-1
Externí odkaz:
https://doaj.org/article/c917e04d846b4571aff6d1cd776891e0
Autor:
Frank Msafiri, Agricola Joachim, Kathrin Held, Yuka Nadai, Raquel Matavele Chissumba, Christof Geldmacher, Said Aboud, Wolfgang Stöhr, Edna Viegas, Arne Kroidl, Muhammad Bakari, Patricia J. Munseri, Britta Wahren, Eric Sandström, Merlin L. Robb, Sheena McCormack, Sarah Joseph, Ilesh Jani, Guido Ferrari, Mangala Rao, Gunnel Biberfeld, Eligius Lyamuya, Charlotta Nilsson
Publikováno v:
Microorganisms, Vol 8, Iss 11, p 1722 (2020)
Antibody responses that correlated with reduced risk of HIV acquisition in the RV144 efficacy trial were assessed in healthy African volunteers who had been primed three times with HIV-DNA (subtype A, B, C) and then randomized into two groups; group
Externí odkaz:
https://doaj.org/article/33fc5d4954f946749c536f9a5caab9a1
Autor:
Agricola Joachim, Frank Msafiri, Sayali Onkar, Patricia Munseri, Said Aboud, Eligius F. Lyamuya, Muhammad Bakari, Erik Billings, Merlin L. Robb, Britta Wahren, Fred S. Mhalu, Eric Sandström, Mangala Rao, Charlotta Nilsson, Gunnel Biberfeld
Publikováno v:
Vaccines, Vol 8, Iss 4, p 681 (2020)
We evaluated antibody responses to the human immunodeficiency virus (HIV) envelope variable regions 1 and 2 (V1V2) in 29 vaccinees who had received three HIV-1 DNA immunizations and two HIV-modified vaccinia virus Ankara (MVA) boosts in the phase I/I
Externí odkaz:
https://doaj.org/article/06fc6daf16b849f1aba182d32ba796ee
Autor:
Edna O Viegas, Arne Kroidl, Patricia J Munseri, Marco Missanga, Charlotta Nilsson, Nelson Tembe, Asli Bauer, Agricola Joachim, Sarah Joseph, Philipp Mann, Christof Geldmacher, Sue Fleck, Wolfgang Stöhr, Gabriella Scarlatti, Said Aboud, Muhammad Bakari, Leonard Maboko, Michael Hoelscher, Britta Wahren, Merlin L Robb, Jonathan Weber, Sheena McCormack, Gunnel Biberfeld, Ilesh V Jani, Eric Sandström, Eligius Lyamuya, TaMoVac study group
Publikováno v:
PLoS ONE, Vol 13, Iss 11, p e0206838 (2018)
BackgroundWe evaluated the safety and immunogenicity of (i) an intradermal HIV-DNA regimen given with/without intradermal electroporation (EP) as prime and (ii) the impact of boosting with modified vaccinia virus Ankara (HIV-MVA) administered with or
Externí odkaz:
https://doaj.org/article/8aaff0f6894749a39798ad0d258c5204
Autor:
Stefan Petkov, Elizaveta Starodubova, Anastasia Latanova, Athina Kilpeläinen, Oleg Latyshev, Simons Svirskis, Britta Wahren, Francesca Chiodi, Ilya Gordeychuk, Maria Isaguliants
Publikováno v:
PLoS ONE, Vol 13, Iss 6, p e0197902 (2018)
Optimization of DNA vaccine delivery improves the potency of the immune response and is crucial to clinical success. Here, we inquired how such optimization impacts the magnitude of the response, its specificity and type. BALB/c mice were DNA-immuniz
Externí odkaz:
https://doaj.org/article/1db946fb6a784d978a81b15e638a219d
Autor:
Britta Wahren, Margaret A. Liu
Publikováno v:
Vaccines, Vol 2, Iss 4, Pp 785-796 (2014)
This special issue is focused on DNA vaccines, marking the two decades since the first demonstration of pre-clinical protection was published in Science (Ulmer et al.; Heterologous protection against influenza by injection of DNA encoding a viral pro
Externí odkaz:
https://doaj.org/article/a28abb05fd564affae1094726cf0fabb